The mAI-Health app is now available for download on the Google Play Store.

The app is a research data collection tool used in the Digital biomarkers development, validation, and verification study (dBM-DEV study) (NCT06444789). Currently, the app is only available to participants enrolled in the study across Germany, France, Spain, and the UK.

The dBM-DEV study is part of the AI-PROGNOSIS project and focuses on developing digital biomarkers (dBMs) for Parkinson’s disease (PD) symptoms, particularly REM sleep behaviour disorder (RBD) and daytime sleepiness.

Link to the app on the Google Play Store: mAI-Health - Apps on Google Play.